Todd Georgieff has had an extensive career in the healthcare and pharmaceutical industries, spanning nearly 30 years. He holds a Bachelor of Science in Pharmacy from the University of Toronto and an MBA from York University. His professional experience includes managing global drug development programs and leading clinical operations teams across various therapeutic areas such as oncology, immunology, and ophthalmology.

Georgieff has worked on numerous high-profile projects, including digital protocol development and comprehensive genomic screening, particularly at major companies like Roche and Genentech. He has also contributed to industry collaborations, such as TransCelerate’s Digital Data Flow initiative and the Precision Cancer Consortium. Additionally, he has served in leadership roles overseeing large-scale organizational changes and process improvements, and he has a significant background in teaching graduate-level courses on health management.

Beyond his industry roles, Todd Georgieff is actively involved in the Canadian Pulmonary Fibrosis Foundation, where he serves as the board chair for Quebec. His personal connection to the disease, through his father-in-law's battle with idiopathic pulmonary fibrosis, drives his commitment to supporting advancements in this field​ (futurpositif)​​ (Applied Clinical Trials)​​ (Xtalks)​​ (Canadian Pulmonary Fibrosis Foundation)​.